期刊文献+

气相色谱法测定人血浆中尼莫地平的浓度 被引量:4

Determination of nimodipine in human plasma by GC
原文传递
导出
摘要 目的:建立人血浆中尼莫地平浓度的气相色谱测定方法。方法:以氢氧化钠碱化样品后用正己烷-乙酸乙酯(1:1,v/v)提取,以硝苯地平作为内标,经SE-30填充柱分离,进入氢火焰离子化检测器检测。结果:尼莫地平浓度在1~300ng/mL范围呈线性相关。最低检测限约为1 ng/mL。三种浓度的平均回收率为88.1%~95.2%,日内RSD为1.6%~7.1%,日间RSD为3.6%~5.0%。结论:本法简便、快速、重现性好,适合用于尼莫地平的人体药代动力学研究。 Objective To establish a GC method for determination of nimodipine in human plasma.Methods After adjustment to a basic pH with sodium hydroxide solution,plasma samples were extracted with n-hexane-ethyl acetate(1:1,v/v) and separated on a SE-30 column with FID as the detector.Results The linear range was 1~300 ng/mL,the detective limit was 1 ng/mL.The recovery was 88.1%~95.2% with the intra-day RSD from 1.6 to 7.1%,and the inter-day RSD from 3.6 to 5.0% at three different concentrations.Conclusion The method was simple,rapid,and successfully applied to study the pharmacokinetics of nimodipine in healthy Chinese volunteers.
出处 《湖南师范大学学报(医学版)》 2011年第3期90-92,共3页 Journal of Hunan Normal University(Medical Sciences)
关键词 气相色谱法 抗高血压药物 尼莫地平 GC chromatography antihypertensive drug nimodipine
  • 相关文献

参考文献6

二级参考文献14

  • 1武琛,王硕,刘巍.颅内动脉瘤手术中尼莫地平与罂粟碱术野灌洗疗效的对照观察[J].中国现代神经疾病杂志,2004,4(6):385-386. 被引量:10
  • 2方琪,董万利,许丽珍.凝血酶对脑组织毒性损伤机制及水蛭素、尼莫地平干预作用的研究[J].临床神经病学杂志,2005,18(5):350-353. 被引量:9
  • 3李光勤 董为伟.尼莫地平对大鼠脑出血周围缺血面积及MPO活性影响的初步报告[J].中国神经精神疾病杂志,1999,25(1):58-59.
  • 4Komotar RJ,Zacharia BE,Valhora R,et al.Advances in vasospasm treatment and prevention[J].Journal of the Neurological Sciences,2007,261(1-2):134-142.
  • 5Schmidt JM,Wartenberg KE,Fernandez A,et al.Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage[J].J Neurosurg,2008,109(6):1052-1059.
  • 6Pearl JD,Macdonald RL.Vasospasm after aneurysmal subarachnoid hemorrhage:need for further study[J].Acta Neurochir Suppl,2008,105:207-210.
  • 7Harrod CG,Bendok BR,Batjer HH,et al.Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage:a review[J].Neurosurgery,2005,56(4):633-654.
  • 8Tomassoni D,Lanari A,Silvestrelli G,et al.Nimodipine and its use in cerebrovascular disease:evidence from recent preclinical and controlled clinical studies[J].Clin Exp Hypertens,2008,30(8):744-766.
  • 9Tomassoni D,Lanari A,Silvestrelli G,et al.Nimodipine and Its Use in Cerebrovascular Disease:Evidence from Recent Preclinical and Controlled Clinical Studies[J].Clinical and Experimental Hypertension,2008,30(8):744-766.
  • 10Hanggi D,Beseoglu K,Turowski B,et al.Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy[J].Clin Neurol Neurosurg,2008,110(8):784-790.

共引文献46

同被引文献36

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部